Cargando…
Evaluation of the Impact of the Cancer Therapy Everolimus on the Central Nervous System in Mice
Cancer and treatments may induce cognitive impairments in cancer patients, and the causal link between chemotherapy and cognitive dysfunctions was recently validated in animal models. New cancer targeted therapies have become widely used, and their impact on brain functions and quality of life needs...
Autores principales: | Dubois, Martine, Le Joncour, Vadim, Tonon, Marie-Christine, Anouar, Youssef, Proust, François, Morin, Fabrice, Gandolfo, Pierrick, Joly, Florence, Hilber, Pascal, Castel, Hélène |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250083/ https://www.ncbi.nlm.nih.gov/pubmed/25436776 http://dx.doi.org/10.1371/journal.pone.0113533 |
Ejemplares similares
-
Down-Regulation of GABA(A) Receptor via Promiscuity with the Vasoactive Peptide Urotensin II Receptor. Potential Involvement in Astrocyte Plasticity
por: Desrues, Laurence, et al.
Publicado: (2012) -
The Autophagy Machinery: A New Player in Chemotactic Cell Migration
por: Coly, Pierre-Michaël, et al.
Publicado: (2017) -
The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features
por: Castel, Hélène, et al.
Publicado: (2017) -
Biomarkers Associated with Cognitive Impairment in Treated Cancer Patients: Potential Predisposition and Risk Factors
por: Castel, Hélène, et al.
Publicado: (2017) -
Development of Novel (111)-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours
por: Poret, Benjamin, et al.
Publicado: (2020)